Evaluation of the prognostic value of centrosome-related genes and assessment of the immune microenvironment in osteosarcoma
We developed and validated a novel CRG-based prognostic score demonstrating potential clinical utility for OS outcome prediction. This molecular score provides mechanistic insights into tumor-immune interactions and offers clinicians a quantitative framework for personalized therapeutic decision-making.
Authors
- Hui Yu (ORCID: https://orcid.org/0000-0003-0074-9153)
- Yue Huang (ORCID: https://orcid.org/0000-0002-4985-3392)
- Guoming Xia (ORCID: https://orcid.org/0000-0002-9871-9210)
- Song Luo (ORCID: https://orcid.org/0000-0003-2404-5177)
- B. A. Long
- Jian‐Hui Liang
Institutions
- Nanchang University (CN)
- Second Hospital of Nanchang (CN)
- First Affiliated Hospital of Nanchang University (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Biochemical and Biophysical Research Communications
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.bbrc.2025.152739
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00